FK 506 ‘Rescue’ Immunosuppression for Obliterative Bronchiolitis After Lung Transplantation
- 1 November 1997
- Vol. 112 (5) , 1175-1179
- https://doi.org/10.1378/chest.112.5.1175
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapyTransplantation Proceedings, 1997
- CYTOLYTIC THERAPY FOR THE TREATMENT OF BRONCHIOLITIS OBLITERANS SYNDROME FOLLOWING LUNG TRANSPLANTATIONTransplantation, 1996
- Clinical trial of tacrolimus versus cyclosporine in lung transplantationThe Annals of Thoracic Surgery, 1995
- Bronchiolitis Obliterans in Recipients of Single, Double, and Heart-Lung TransplantationChest, 1995
- Bronchiolitis Obliterans in Single-Lung Transplant RecipientsChest, 1995
- A Decade of Lung TransplantationAnnals of Surgery, 1993
- Cytomegalovirus Infection and Pneumonitis: Impact after Isolated Lung TransplantationAmerican Review of Respiratory Disease, 1993
- CONVERSION OF LIVER ALLOGRAFT RECIPIENTS FROM CYCLOSPORINE TO FK506 IMMUNOSUPPRESSIVE THERAPY—A CLINICOPATHOLOGIC STUDY OF 96 PATIENTSTransplantation, 1992
- EFFICACY OF TRANSBRONCHIAL LUNG BIOPSY IN THE DIAGNOSIS OF BRONCHIOLITIS OBLITERANS IN HEART-LUNG TRANSPLANT RECIPIENTSTransplantation, 1989
- Post-Transplant Obliterative Bronchiolitis and Other Late Lung Sequelae in Human Heart-Lung TransplantationChest, 1984